Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41,009,592
-
Total 13F shares
-
181,737
-
Share change
-
-31,004
-
Total reported value
-
$1,320,000
-
Put/Call ratio
-
0%
-
Price per share
-
$7.26
-
Number of holders
-
21
-
Value change
-
-$246,428
-
Number of buys
-
6
-
Number of sells
-
8
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q3 2016
As of 30 Sep 2016,
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
181,737 shares.
The largest 10 holders included
TOCQUEVILLE ASSET MANAGEMENT L.P., BARCLAYS PLC, PNC Financial Services Group, Inc., MORGAN STANLEY, Acrospire Investment Management LLC, WELLS FARGO & COMPANY/MN, DEUTSCHE BANK AG\, FineMark National Bank & Trust, SIMPLEX TRADING, LLC, and Penserra Capital Management LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.